Litigation Challenges Prioritization of Race or Ethnicity in Allocating COVID-19 Therapies
Within a few weeks after the New York guidelines were issued, the federal lawsuits commenced.
therapeutic monoclonal antibodies
-
Read more: Litigation Challenges Prioritization of Race or Ethnicity in Allocating COVID-19 Therapies -
Read more: How to Fairly Allocate Scarce COVID-19 Therapies How to Fairly Allocate Scarce COVID-19 Therapies
The same ethical goals identified for vaccine allocation are also relevant for COVID-19 therapy allocation.
-
Read more: 3 Challenges to Patents on Therapeutic Monoclonal Antibodies 3 Challenges to Patents on Therapeutic Monoclonal Antibodies
Three developments may have effects on the use of patents to fend off competition for therapeutic monoclonal antibodies.
